Skip to main content

Application of Pathological Staging in Esophageal Squamous Cell Carcinoma

  • Protocol
  • First Online:
Book cover Esophageal Squamous Cell Carcinoma

Part of the book series: Methods in Molecular Biology ((MIMB,volume 2129))

Abstract

Pathological staging is the most important factor that determines the prognosis and management of patients with esophageal squamous cell carcinoma. The method for the pathological staging in esophageal squamous cell carcinoma involves assessment of standard parameters—extent of tumor (T), lymph node status (N), presence of distant metastasis (M), as well as grade (G) and anatomical location of the carcinoma. In addition, other relevant factors, such as use of neoadjuvant therapy, could affect the pathological staging of esophageal squamous cell carcinoma.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Lam AK (2018) Application of pathological staging in esophageal adenocarcinoma. Methods Mol Biol 1756:93–103

    Article  CAS  Google Scholar 

  2. (2010) Esophagus and Esophagogastric junction. In: Chapter 10: AJCC cancer staging manual, 7th. edn, Part 3. Springer, New York, pp p103–p155

    Google Scholar 

  3. Rice TW, Blackstone EH, Rusch VW (2010) 7th edition of the AJCC cancer staging manual: esophagus and esophagogastric junction. Ann Surg Oncol 17:1721–1724

    Article  Google Scholar 

  4. Rice TW, Kelsen D, Blackstone E, Ishwaran H, Patil DT, Bass AJ, Erasmus JJ, Gerdes H, Hofstetter WL (2016) Esophagus and Esophagogastric junction. In: Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR, Sullivan DC, Jessup JM, Brierley JD, Gaspar LE, Schilsky RL, Balch CM, Winchester DP, Asare EA, Madera M, Gress DM, Meyer LR (eds) Chapter 16: AJCC cancer staging manual, 8th edn. Springer, New York, pp 185–202

    Google Scholar 

  5. D'Journo XB (2018) Clinical implication of the innovations of the 8(th) edition of the TNM classification for esophageal and esophago-gastric cancer. J Thorac Dis 10:S2671–S2681

    Article  Google Scholar 

  6. Rizk NP, Ishwaran H, Rice TW, Chen LQ, Schipper PH, Kesler KA, Law S, Lerut TE, Reed CE, Salo JA, Scott WJ, Hofstetter WL, Watson TJ, Allen MS, Rusch VW, Blackstone EH (2010) Optimum lymphadenectomy for esophageal cancer. Ann Surg 251:46–50

    Article  Google Scholar 

  7. Chen YJ, Schultheiss TE, Wong JY, Kernstine KH (2009) Impact of the number of resected and involved lymph nodes on esophageal cancer survival. J Surg Oncol 100:127–132

    Article  Google Scholar 

  8. Peyre CG, Hagen JA, DeMeester SR, Altorki NK, Ancona E, Griffin SM, Hölscher A, Lerut T, Law S, Rice TW, Ruol A, van Lanschot JJ, Wong J, DeMeester TR (2008) The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection. Ann Surg 248:549–556

    Article  Google Scholar 

  9. Rice TW, Ishwaran H, Hofstetter WL, Schipper PH, Kesler KA, Law S, Lerut EM, Denlinger CE, Salo JA, Scott WJ, Watson TJ, Allen MS, Chen LQ, Rusch VW Cerfolio RJ, Luketich JD, Duranceau A, Darling GE, Pera M, Apperson-Hansen C, Blackstone EH (2017) Esophageal cancer: associations with (pN+) lymph node metastases. Ann Surg 265:122–129

    Article  Google Scholar 

  10. Brown IS, Fujii S, Kawachi H, Lam AK, Saito T Oesophageal squamous cell carcinoma NOS. In: Odze RD, Lam AK, Ochiai A, Washington MK (eds) Chapter 2: WHO classification of tumours, 5th edn, pp 48–53

    Google Scholar 

  11. Rice TW, Ishwaran H, Ferguson MK, Blackstone EH, Goldstraw P (2017) Cancer of the esophagus and esophagogastric junction: an eighth edition staging primer. J Thorac Oncol 12:36–42

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alfred K. Lam .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Science+Business Media, LLC, part of Springer Nature

About this protocol

Check for updates. Verify currency and authenticity via CrossMark

Cite this protocol

Lam, A.K. (2020). Application of Pathological Staging in Esophageal Squamous Cell Carcinoma. In: Lam, A. (eds) Esophageal Squamous Cell Carcinoma. Methods in Molecular Biology, vol 2129. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-0377-2_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-0716-0377-2_3

  • Published:

  • Publisher Name: Humana, New York, NY

  • Print ISBN: 978-1-0716-0376-5

  • Online ISBN: 978-1-0716-0377-2

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics